Executive Summary
Key Takeaways
- Medicare Advantage payment rates face political pressure: A secretive group funded $3.1 million in ads to generate identical public comments.
- EHR vendors risk liability for data access: AADJ sues Epic because separate MyChart portals prevent patients from aggregating records for SSDI claims.
- Medicaid drug budgets swell: Net spending rose 46% from FY2019 to FY2024 driven by specialty drugs.
- FDA accelerates rare disease reviews: The National Priority Voucher program approved a myeloma treatment in 55 days.
- Preventive care costs may rise: New guidelines recommend statins for adults as young as 30 with high LDL.
Key Themes
Major trends and developments identified from this week's coverage
FDA Regulatory Changes
Agency upgrades data tools and accelerates rare disease approvals.
Medicare Advantage Payment Pressure
Insurers lobby for higher rates while plan terminations disrupt beneficiaries.
Health Data Interoperability Litigation
Lawsuits target EHR vendors over patient access barriers.
Public Health Leadership Instability
Political appointments clash with career staff and public opinion.
Key Players
Top companies, people, and technologies mentioned this week
8 articles
Regulatory agency targeting telehealth marketing of GLP-1 drugs and approving Leucovorin (+7 more)
2 articles
Former US President mentioned in a satirical context regarding the suppression of scientists. (+1 more)
2 articles
Health and Human Services Secretary advocating for the 'Make America Healthy Again' (MAHA) agenda, facing pressure to moderate anti-vaccine stances. (+1 more)
2 articles
A newsroom producing in-depth journalism about health issues and a core operating program at KFF. (+1 more)
4 articles
FDA Commissioner who stated the previous systems were outdated and fragmented. (+3 more)
2 articles
Agency co-managing VAERS with the FDA. (+1 more)
2 articles
Former FDA official whose exit is discussed in the newsletter (+1 more)
3 articles
Publisher of the issue brief analyzing Medicaid prescription drug data and policy. (+2 more)
2 articles
Senior writer and Pharmalot columnist at STAT (+1 more)
2 articles
Author of the issue brief '5 Key Facts About Medicaid Prescription Drugs'. (+1 more)
Regulatory & Policy Updates
FDA launches real-time adverse event tracking.
Replaces 7 older databases with single platform for public data access.
CMS/MEDICARECMS faces lobbying pressure on 2027 rates.
Industry group opposes flat reimbursement proposals.
FDAFDA vaccine chief resigns amid policy conflicts.
Trust in career scientists exceeds political leaders.
FDAFDA meets states on Canadian drug importation.
Section 804 program implementation continues.
Technology & Innovation
FDA deploys unified adverse event monitoring system.
Publishes safety reports in real-time instead of quarterly.
Hospital infection software fails to prevent errors.
Barcode scanning failures identified in antimicrobial stewardship workflows.
Telecare call centers miss quality standards.
Norway study shows operators lack integrated patient knowledge.
Market & Competitive Intelligence
Medicare Advantage
Partnership2.6 million beneficiaries switch plans after 2025 terminations.
Invivyd
FundingCompany hires Michael Mina as chief medical officer.
Medicaid
FundingOutpatient prescription drug spending jumps 46%.
What to Watch
RFK Jr. Vaccine Policy
Q2 202686% of voters support vaccines despite HHS agenda.
Statin Guidelines
ImmediateAge threshold drops to 30 for high LDL patients.
Epic Antitrust Case
2026Texas court rules on 'covered entity' status.
Editor's Picks
AI-recommended articles based on relevance and quality
Medicare Advantage ‘Dark Money’ Group Attempts To Win Higher Payments for Insurance Companies
Most Medicare Beneficiaries Affected by Plan Terminations in 2025 Have Robust Medicare Advantage Options in 2026 | KFF
‘Dark Money’ Group Angles for Higher Medicare Advantage Payments
AADJ v. Epic
Breast Cancer Screening Knowledge and Sentiments in Singaporean Women: Mixed Methods Study Using Topic Modeling, Sentiment Analysis, and Structured Questionnaire Data
Top Sources
Want personalized briefings?
Kelp creates AI-powered briefings tailored to your specific interests and sources. Get the insights that matter most to you.
Start Your Free Briefing